Ignite Creation Date:
2024-05-05 @ 7:35 PM
Last Modification Date:
2024-10-26 @ 9:51 AM
Study NCT ID:
NCT00697632
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2008-05-14
Brief Title:
Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies
Sponsor:
Mirati Therapeutics Inc
Organization:
Mirati Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-06
Start Date Type:
None
Primary Completion Date:
2018-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-14
First Submit QC Date:
June 12 2008
Study First Post Date:
2008-06-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-11
Last Update Post Date:
2019-02-12
Last Update Post Date Type:
ACTUAL